Effects of iron oxide nanoparticles: Cytotoxicity, genotoxicity, developmental toxicity, and neurotoxicity

Environmental and Molecular Mutagenesis

Volumn 56, Issue 2, 2015, Pages 125-148

  Valdiglesias, Vanessa ^a   Kiliç, Gözde ^a   Costa, Carla ^b,c   Fernández Bertólez, Natalia ^a   Pásaro, Eduardo ^a   Teixeira, João Paulo ^b,c   Laffon, Blanca ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b NATIONAL INSTITUTE OF HEALTH   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Cytotoxicity; Developmental toxicity; Genotoxicity; Iron oxide nanoparticles; Neurotoxicity

Indexed keywords

DAUNORUBICIN; FERRIC OXIDE; FERRITIN; FERROMAGNETIC MATERIAL; IRON NANOPARTICLE; IRON OXIDE NANOPARTICLE; MAGNETITE NANOPARTICLE; NERVE GROWTH FACTOR; PROTEIN P53; RESAZURIN; UNCLASSIFIED DRUG; CHEMOTACTIC FACTOR; FERRIC ION; METAL NANOPARTICLE; MUTAGENIC AGENT;

BLOOD BRAIN BARRIER; CELL VIABILITY; CYTOTOXICITY; DEVELOPMENTAL TOXICITY; DNA DAMAGE; DRUG DELIVERY SYSTEM; GENE EXPRESSION; GENOTOXICITY; HEALTH HAZARD; HUMAN; LIPID PEROXIDATION; LONG TERM CARE; MAGNETISM; MATERIAL COATING; MITOCHONDRIAL MEMBRANE; NERVE CELL; NEUROTOXICITY; NONHUMAN; PARTICLE SIZE; REVIEW; SURFACE PROPERTY; ANIMAL; DRUG EFFECTS; EMBRYO DEVELOPMENT; MITOCHONDRIAL MEMBRANE POTENTIAL; MUTAGEN TESTING; NEUROTOXICITY SYNDROMES; PATHOLOGY;

ANIMALS; CHEMOTACTIC FACTORS; EMBRYONIC DEVELOPMENT; FERRIC COMPOUNDS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; METAL NANOPARTICLES; MUTAGENICITY TESTS; MUTAGENS; NEUROTOXICITY SYNDROMES;

EID: 84925247550     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21909     Document Type: Review

References (130)

1. Ahamed M, Alhadlaq HA, Alam J, Khan MA, Ali D, Alarafi S. 2013. Iron oxide nanoparticle-induced oxidative stress and genotoxicity in human skin epithelial and lung epithelial cell lines. Curr Pharm Des 2013;19:6681-90.
2. Alwi R, Telenkov S, Mandelis A, Leshuk T, Gu F, Oladepo S, Michaelian K. 2012. Silica-coated super paramagnetic iron oxide nanoparticles (SPION) as biocompatible contrast agent in biomedical photoacoustics. Biomed Opt Express 3:2500-2509.
3. Apopa PL, Qian Y, Shao R, Guo NL, Schwegler-Berry D, Pacurari M, Porter D, Shi X, Vallyathan V, Castranova V, et al. 2009. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part Fibre Toxicol 6:1.
4. Au C, Mutkus L, Dobson A, Riffle J, Lalli J, Aschner M. 2007. Effects of nanoparticles on the adhesion and cell viability on astrocytes. Biol Trace Elem Res 120:248-256.
5. Au K-W, Liao S-Y, Lee Y-K, Lai W-H, Ng K-M, Chan Y-C, Yip M-C, Ho C-Y, Wu E X, Li RA, et al. 2009. Effects of iron oxide nanoparticles on cardiac differentiation of embryonic stem cells. Biochem Biophys Res Commun 379:898-903.
6. Auffan M, Decome L, Rose J, Orsiere T, De Meo M, Briois V, Chaneac C, Olivi L, Berge-Lefranc J-L, Botta A, et al. 2006. In vitro interactions between DMSA-coated maghemite nanoparticles and human fibroblasts: A physicochemical and cyto-genotoxical study. Environ Sci Technol 40:4367-4373.
7. Auffan M, Achouak W, Rose J, Roncato M-A, Chanéac C, Waite D T, Masion A, Woicik J C, Wiesner M R, Bottero J-Y. 2008. Relation between the redox state of iron-based nanoparticles and their cytotoxicity toward Escherichia coli. Environ Sci Technol 42:6730-6735.
8. Auffan M, Rose J, Bottero J-Y, Lowry GV, Jolivet J-P, Wiesner MR. 2009. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat Nanotechnol 4:634-641.
9. Berry CC, Wells S, Charles S, Curtis ASG. 2003. Dextran and albumin derivatised iron oxide nanoparticles: Influence on fibroblasts in vitro. Biomaterials 24:4551-4557.
10. Bhattacharya K, Davoren M, Boertz J, Schins RP, Hoffmann E, Dopp E. 2009. Titanium dioxide nanoparticles induce oxidative stress and DNA-adduct formation but not DNA-breakage in human lung cells. Part Fibre Toxicol 6:17.
11. Bigini P, Diana V, Barbera S, Fumagalli E, Micotti E, Sitia L, Paladini A, Bisighini C, De Grada L, Coloca L, et al. 2012. Longitudinal tracking of human fetal cells labeled with super paramagnetic iron oxide nanoparticles in the brain of mice with motor neuron disease. PLoS One 7:e32326.
12. Bjørnerud A, Johansson L. 2004. The utility of superparamagnetic contrast agents in MRI: Theoretical consideration and applications in the cardiovascular system. NMR Biomed 17:465-477.
13. Borm PJA, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Lademann J, et al. 2006. The potential risks of nanomaterials: A review carried out for ECETOC. Part Fibre Toxicol 3:11.
14. Bourrinet P, Bengele HH, Bonnemain B, Dencausse A, Idee J-M, Jacobs PM, Lewis JM. 2006. Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest Radiol 41:313-324.
15. Buyukhatipoglu K, Clyne AM. 2011. Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation. J Biomed Mater Res A 96:186-195.
16. Buzea C, Pacheco II, Robbie K. 2007. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2:MR17-MR71.
17. Card JW, Zeldin DC, Bonner JC, Nestmann ER. 2008. Pulmonary applications and toxicity of engineered nanoparticles. Am J Physiol Lung Cell Mol Physiol 295:l400-1411.
18. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager JJ. 2008. Unique cellular interaction of silver nanoparticles: Size-dependent generation of reactive oxygen species. J Phys Chem B 112:13608-13619.
19. Chen Z, Yin J-J, Zhou Y-T, Zhang Y, Song L, Song M, Hu S, Gu N. 2012. Dual enzyme-like activities of iron oxide nanoparticles and their implication for diminishing cytotoxicity. ACS Nano 6:4001-4012.
20. Dan M, Scott DF, Hardy PA, Wydra RJ, Hilt JZ, Yokel RA, Bae Y. 2013. Block copolymer cross-linked nanoassemblies improve particle stability and biocompatibility of superparamagnetic iron oxide nanoparticles. Pharm Res 30:552-561.
21. Das M, Saxena N, Dwivedi P D .2009. Emerging trends of nanoparticles application in food technology: Safety paradigms. Nanotoxicology 3:10-18.
22. Dwivedi S, Siddiqui MA, Farshori NN, Ahamed M, Musarrat J, Al-Khedhairy AA. 2014. Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells. Colloids Surf B Biointerfaces 122:209-215.
23. Eaton JW, Qian M. 2002. Molecular bases of cellular iron toxicity. Free Radic Biol Med 32:833-840.
24. Estevanato L, Cintra D, Baldini N, Portilho F, Barbosa L, Martins O, Lacava B, Miranda-Vilela AL, Tedesco AC, Báo S, et al. 2011. Preliminary biocompatibility investigation of magnetic albumin nanosphere designed as a potential versatile drug delivery system. Int J Nanomed 6:1709-1717.
25. Freitas MLL, Silva LP, Azevedo RB, Garcia VAP, Lacava LM, Grisólia CK, Lucci CM, Morais PC, Da Silva MF, Buske N, et al. 2002. A double-coated magnetite-based magnetic fluid evaluation by cytometry and genetic tests. J Magn Magn Mater 252:396-398.
26. Geppert M, Hohnholt M, Gaetjen L, Grunwald I, Bäumer M, Dringen R. 2009. Accumulation of iron oxide nanoparticles by cultured brain astrocytes. J Biomed Nanotechnol 5:285-293.
27. Geppert M, Hohnholt MC, Thiel K, Nürnberger S, Grunwald I, Rezwan K, Dringen R. 2011. Uptake of dimercaptosuccinate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes. Nanotechnology 22:145101.
28. Geppert M, Hohnholt MC, Nürnberger S, Dringen R. 2012. Ferritin up-regulation and transient ROS production in cultured brain astrocytes after loading with iron oxide nanoparticles. Acta Biomater 8:3832-3839.
29. Gould P. 2006. Nanomagnetism shows in vivo potential. Nano Today 1:34-39.
30. Guichard Y, Schmit J, Darne C, Gaté L, Goutet M, Rousset D, Rastoix O, Wrobel R, Witschger O, Martin A, et al. 2012. Cytotoxicity and genotoxicity of nanosized and microsized titanium dioxide and iron oxide particles in Syrian hamster embryo cells. Ann Occup Hyg 56:631-644.
31. Gupta AK, Gupta M. 2005. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26:3995-4021.
32. Gurr J-R, Wang ASS, Chen C-H, Jan K-Y. 2005. Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells. Toxicology 213:66-73.
33. Hanini A, Schmitt A, Kacem K, Chau F, Ammar S, Gavard J. 2011. Evaluation of iron oxide nanoparticle biocompatibility. Int J Nanomed 6:787-794.
34. Hildebrand H, Kühnel D, Potthoff A, Mackenzie K, Springer A, Schirmer K. 2010. Evaluating the cytotoxicity of palladium/magnetite nano-catalysts intended for wastewater treatment. Environ Pollut 158:65-73.
35. Hohnholt MC, Dringen R. 2013. Uptake and metabolism of iron and iron oxide nanoparticles in brain astrocytes. Biochem Soc Trans 41:1588-1592.
36. Hohnholt MC, Geppert M, Dringen R. 2010. Effects of iron chelators, iron salts, and iron oxide nanoparticles on the proliferation and the iron content of oligodendroglial OLN-93 cells. Neurochem Res 35:1259-1268.
37. Hohnholt MC, Geppert M, Dringen R. 2011. Treatment with iron oxide nanoparticles induces ferritin synthesis but not oxidative stress in oligodendroglial cells. Acta Biomater 7:3946-3954.
38. Hohnholt MC, Geppert M, Luther EM, Petters C, Bulcke F, Dringen R. 2013. Handling of iron oxide and silver nanoparticles by astrocytes. Neurochem Res 38:227-239.
39. Hong SC, Lee JH, Lee J, Kim HY, Park JY, Cho J, Lee J, Han D-W. 2011. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups. Int J Nanomed 6:3219-3231.
40. Huang D-M, Hsiao J-K, Chen Y-C, Chien L-Y, Yao M, Chen Y-K, Ko B-S, Hsu S-C, Tai L-A, Cheng H-Y, et al. 2009. The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles. Biomaterials 30:3645-3651.
41. 4@mesoporous silica composites for drug delivery and bioadsorption. J Colloid Interface Sci 376:312-321.
42. Huber DL. 2005. Synthesis, properties, and applications of iron nanoparticles. Small Weinh Bergstr Ger 1:482-501.
43. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. 2005. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol Vitro Int J Publ Assoc BIBRA 19:975-983.
44. Iavicoli I, Leso V, Bergamaschi A. 2012. Toxicological effects of titanium dioxide nanoparticles: A review of in vivo studies. J Nanomater 2012, Article ID 964381, 36 pages. DOI:10.1155/2012/964381.
45. Jeng HA, Swanson J. 2006. Toxicity of metal oxide nanoparticles in mammalian cells. J Environ Sci Health Part A 41:2699-2711.
46. Johnston H, Pojana G, Zuin S, Jacobsen NR, Moller P, Loft S, Semmler-Behnke M, McGuiness C, Balharry D, Marcomini A, et al. 2013. Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: Potential solutions to current and future challenges. Crit Rev in Toxicol 43:1-20.
47. Jordan A, Scholz R, Wust P, Fähling H, Roland F. 1999. Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mater 201:413-419.
48. Karlsson HL, Cronholm P, Gustafsson J, Möller L. 2008. Copper oxide nanoparticles are highly toxic: A comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol 21:1726-1732.
49. Karlsson HL, Gustafsson J, Cronholm P, Möller L. 2009. Size-dependent toxicity of metal oxide particles-A comparison between nano- and micrometer size. Toxicol Lett 188:112-118.
50. Kenzaoui BH, Bernasconi CC, Hofmann H, Juillerat-Jeanneret L. 2012. Evaluation of uptake and transport of ultrasmall superparamagnetic iron oxide nanoparticles by human brain-derived endothelial cells. Nanomed 7:39-53.
51. Kim JA, Lee N, Kim BH, Rhee WJ, Yoon S, Hyeon T, Park TH. 2011. Enhancement of neurite outgrowth in PC12 cells by iron oxide nanoparticles. Biomaterials 32:2871-2877.
52. Kim J-E, Shin J-Y, Cho M-H. 2012. Magnetic nanoparticles: An update of application for drug delivery and possible toxic effects. Arch Toxicol 86:685-700.
53. Kim Y, Kong SD, Chen L-H, Pisanic II TR, Jin S, Shubayev VI. 2013. In vivo nanoneurotoxicity screening using oxidative stress and neuroinflammation paradigms. Nanomed Nanotechnol Biol Med 9:1057-1066.
54. Könczöl M, Ebeling S, Goldenberg E, Treude F, Gminski R, Gieré R, Grobéty B, Rothen-Rutishauser B, Merfort I, Mersch-Sundermann V. 2011. Cytotoxicity and genotoxicity of size-fractionated iron oxide (magnetite) in A549 human lung epithelial cells: role of ROS, JNK, and NF-κB. Chem Res Toxicol 24:1460-1475.
55. Kumari M, Rajak S, Singh SP, Kumari SI, Kumar PU, Murty USN, Mahboob M, Grover P, Rahman MF. 2012. Repeated oral dose toxicity of iron oxide nanoparticles: biochemical and histopathological alterations in different tissues of rats. J Nanosci Nanotechnol 12:2149-2159.
56. Kunzmann A, Andersson B, Vogt C, Feliu N, Ye F, Gabrielsson S, Toprak MS, Buerki-Thurnherr T, Laurent S, Vahter M, et al. 2011. Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicol Appl Pharmacol 253:81-93.
57. Landsiedel R, Fabian E, Ma-Hock L, van Ravenzwaay B, Wohlleben W, Wiench K, Oesch F. 2012. Toxico-/biokinetics of nanomaterials. Arch Toxicol 86:1021-1060.
58. Lee J-H, Huh Y-M, Jun Y, Seo J, Jang J, Song H-T, Kim S, Cho E-J, Yoon H-G, Suh J-S, et al. 2007. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 13:95-99.
59. Levy M, Lagarde F, Maraloiu VA, Blanchin MG, Gendron F, Wilhelm C, Gazeau F. 2010. Degradability of superparamagnetic nanoparticles in a model of intracellular environment: Follow-up of magnetic, structural and chemical properties. Nanotechnology 21:395103.
60. Li L, Mak K Y, Shi J, Koon HK, Leung CH, Wong CM, Leung CW, Mak CSK, Chan NMM, Zhong W, et al. 2012. Comparative in vitro cytotoxicity study on uncoated magnetic nanoparticles: effects on cell viability, cell morphology, and cellular uptake. J Nanosci Nanotechnol 12:9010-9017.
61. Lu C-W, Hung Y, Hsiao J-K, Yao M, Chung T-H, Lin Y-S, Wu S-H, Hsu S-C, Liu H-M, Mou C-Y, et al. 2007. Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett 7:149-154.
62. Luther EM, Petters C, Bulcke F, Kaltz A, Thiel K, Bickmeyer U, Dringen R. 2013. Endocytotic uptake of iron oxide nanoparticles by cultured brain microglial cells. Acta Biomater 9:8454-8465.
63. 4-nanoparticle induces hepatic and renal tissue injury via oxidative stress in mice. Int J Nanomed 7:4809-4818.
64. Magdolenova Z, Lorenzo Y, Collins A, Dusinska M. 2012. Can standard genotoxicity tests be applied to nanoparticles? J Toxicol Environ Health A 75:800-806.
65. Magdolenova Z, Drlickova M, Henjum K, Rundén-Pran E, Tulinska J, Bilanicova D, Pojana G, Kazimirova A, Barancokova M, Kuricova M, et al. 2013. Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles. Nanotoxicology (in press). DOI: 10.3109/17435390.2013.847505.
66. Mahmoudi M, Simchi A, Milani A S, Stroeve P. 2009. Cell toxicity of superparamagnetic iron oxide nanoparticles. J Colloid Interface Sci. 336:510-518.
67. Mahon E, Hristov DL, Dawson KA. 2012. Stabilising fluorescent silica nanoparticles against dissolution effects for biological studies. Chem Commun 48:7970-7972.
68. Malvindi MA, De Matteis V, Galeone A, Brunetti V, Anyfantis GC, Athanassiou A, Cingolani R, Pompa PP. 2014. Toxicity assessment of silica coated iron oxide nanoparticles and biocompatibility improvement by surface engineering. PLoS One 9:e85835.
69. McBain SC, Griesenbach U, Xenariou S, Keramane A, Batich CD, Alton EWFW, Dobson J. 2008. Magnetic nanoparticles as gene delivery agents: Enhanced transfection in the presence of oscillating magnet arrays. Nanotechnology 19:405102.
70. Mesárošová M, Kozics K, Bábelová A, Regendová E, Pastorek M, Vnuková D, Buliaková B, Rázga F, Gábelová A. 2014. The role of reactive oxygen species in the genotoxicity of surface-modified magnetite nanoparticles. Toxicol Lett 226:303-313.
71. Møller P, Jacobsen NR, Folkmann JK, Danielsen PH, Mikkelsen L, Hemmingsen JG, Vesterdal LK, Forchhammer L, Wallin H, Loft S. 2010. Role of oxidative damage in toxicity of particulates. Free Radic Res 44:1-46.
72. Na HB, Palui G, Rosenberg JT, Ji X, Grant SC, Mattoussi H. 2012. Multidentate catechol-based polyethylene glycol oligomers provide enhanced stability and biocompatibility to iron oxide nanoparticles. ACS Nano 6:389-399.
73. Naqvi S, Samim M, Abdin M, Ahmed FJ, Maitra A, Prashant C, Dinda AK. 2010. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int J Nanomed 5:983-989.
74. 2, ZnO and CuO nanomaterials on Xenopus laevis. Chemosphere 83:1053-1061.
75. Nel A, Xia T, Mädler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311:622-627.
76. Noori A, Parivar K, Modaresi M, Messripour M, Yousefi MH, Amiri GR. 2011. Effect of magnetic iron oxide nanoparticles on pregnancy and testicular development of mice. Afr J Biotechnol 10:1221-1227.
77. Oberdorster G, Stone V, Donaldson K. 2008. Toxicology of nanoparticles: A historical perspective. Nanotoxicology 1:2-25.
78. Pan Y, Leifert A, Ruau D, Neuss S, Bornemann J, Schmid G, Brandau W, Simon U, Jahnen-Dechent W. 2009. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small Weinh Bergstr Ger 5:2067-2076.
79. Pankhurst QA, Connolly J, Jones SK, Dobson J. 2003. Applications of magnetic nanoparticles in biomedicine. J Phys Appl Phys 36:r167.
80. Pisanic TR 2nd, Blackwell JD, Shubayev VI, Fiñones RR, Jin S. 2007. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 28:2572-2581.
81. Rahman K. 2007. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2:219-236.
82. Rivet CJ, Yuan Y, Borca-Tasciuc D-A, Gilbert RJ. 2012. Altering iron oxide nanoparticle surface properties induce cortical neuron cytotoxicity. Chem Res Toxicol 25:153-161.
83. Rosenberg JT, Sachi-Kocher A, Davidson MW, Grant SC. 2012. Intracellular SPIO labeling of microglia: High field considerations and limitations for MR microscopy. Contrast Media Mol Imaging 7:121-129.
84. Rosi NL, Mirkin CA. 2005. Nanostructures in biodiagnostics. Chem Rev 105:1547-1562.
85. Sadeghiani N, Barbosa LS, Silva LP, Azevedo RB, Morais PC, Lacava ZGM. 2005. Genotoxicity and inflammatory investigation in mice treated with magnetite nanoparticles surface coated with polyaspartic acid. J Magn Magn Mater 289:466-468.
86. Salata O. 2004. Applications of nanoparticles in biology and medicine. J Nanobiotechnol 2:3.
87. Santhosh PB, Ulrih NP. 2013. Multifunctional superparamagnetic iron oxide nanoparticles: Promising tools in cancer theranostics. Cancer Lett 336:8-17.
88. Schäfer R, Kehlbach R, Wiskirchen J, Bantleon R, Pintaske J, Brehm BR, Gerber A, Wolburg H, Claussen CD, Northoff H. 2007. Transferrin receptor upregulation: In vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide. Radiology 244:514-523.
89. Shander A, Cappellini MD, Goodnough LT. 2009. Iron overload and toxicity: The hidden risk of multiple blood transfusions. Vox Sang 97:185-197.
90. Shubayev VI, Pisanic TR 2nd, Jin S. 2009. Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 61:467-477.
91. Singh N, Manshian B, Jenkins GJS, Griffiths SM, Williams PM, Maffeis TGG, Wright CJ, Doak SH. 2009. Nanogenotoxicology: The DNA damaging potential of engineered nanomaterials. Biomaterials 30:3891-3914.
92. Singh N, Jenkins GJS, Asadi R, Doak SH. 2010. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Reviews 2010, 1:5358. DOI: 10.3402/nano.v1i0.5358.
93. Singh N, Jenkins GJS, Nelson BC, Marquis BJ, Maffeis TGG, Brown AP, Williams PM, Wright CJ, Doak SH. 2012. The role of iron redox state in the genotoxicity of ultrafine superparamagnetic iron oxide nanoparticles. Biomaterials 33:163-170.
94. Singh SP, Rahman MF, Murty USN, Mahboob M, Grover P. 2013. Comparative study of genotoxicity and tissue distribution of nano and micron sized iron oxide in rats after acute oral treatment. Toxicol Appl Pharmacol 266:56-66.
95. Skaper SD, Floreani M, Ceccon M, Facci L, Giusti P. 1999. Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin. Ann NY Acad Sci 890:107-118.
96. Soenen SJH, De Cuyper M. 2009. Assessing cytotoxicity of (iron oxide-based) nanoparticles: An overview of different methods exemplified with cationic magnetoliposomes. Contrast Media Mol Imaging 4:207-219.
97. Soenen SJH, De Cuyper M. 2010. Assessing iron oxide nanoparticle toxicity in vitro: Current status and future prospects. Nanomedicine 5:1261-1275.
98. Soenen SJH, Himmelreich U, Nuytten N, De Cuyper M. 2011. Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labeling. Biomaterials 32:195-205.
99. Stohs SJ, Bagchi D. 1995. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 18:321-336.
100. Stroh A, Zimmer C, Gutzeit C, Jakstadt M, Marschinke F, Jung T, Pilgrimm H, Grune T. 2004. Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radic Biol Med 36:976-984.
101. Suh WH, Suslick KS, Stucky GD, Suh Y-H. 2009. Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol 87:133-170.
102. Sun C, Lee JSH, Zhang M. 2008. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 60:1252-1265.
103. Sun Z, Yathindranath V, Worden M, Thliveris JA, Chu S, Parkinson FE, Hegmann T, Miller DW. 2013. Characterization of cellular uptake and toxicity of aminosilane-coated iron oxide nanoparticles with different charges in central nervous system-relevant cell culture models. Int J Nanomed 8:961-970.
104. Szalay B, Tátrai E, Nyíro G, Vezér T, Dura G. 2012. Potential toxic effects of iron oxide nanoparticles in in vivo and in vitro experiments. J Appl Toxicol 32:446-453.
105. Taton TA. 2002. Nanostructures as tailored biological probes. Trends Biotechnol 20:277-279.
106. Tong L, Zhao M, Zhu S, Chen J. 2011. Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging of cancer. Front Med 5:379-387.
107. Unfried K, Albrecht C, Klotz L-O, Von Mikecz A, Grether-Beck S, Schins RPF. 2007. Cellular responses to nanoparticles: Target structures and mechanisms. Nanotoxicology 1:52-71.
108. Wang B, Feng WY, Wang M, Shi JW, Zhang F, Ouyang H, Zhao YL, Chai ZF, Huang YY, Xie YN, et al. 2007. Transport of intranasally instilled fine Fe2O3 particles into the brain: Micro-distribution, chemical states, and histopathological observation. Biol Trace Elem Res 118:233-243.
109. Wang D, Wang L-H, Zhao Y, Lu Y-P, Zhu L. 2010a. Hypoxia regulates the ferrous iron uptake and reactive oxygen species level via divalent metal transporter 1 (DMT1) Exon1B by hypoxia-inducible factor-1. IUBMB Life 62:629-636.
110. Wang J, Chen Y, Chen B, Ding J, Xia G, Gao C, Cheng J, Jin N, Zhou Y, Li X, et al. 2010b. Pharmacokinetic parameters and tissue distribution of magnetic Fe3O4 nanoparticles in mice. Int J Nanomed 5:861-866.
111. Wang Y, Wang B, Zhu M-T, Li M, Wang H-J, Wang M, Ouyang H, Chai Z-F, Feng W-Y, Zhao Y-L. 2011. Microglial activation, recruitment and phagocytosis as linked phenomena in ferric oxide nanoparticle exposure. Toxicol Lett 205:26-37.
112. Wang YX, Hussain SM, Krestin GP. 2001. Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in MR imaging. Eur Radiol 11:2319-2331.
113. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J. 1989. Superparamagnetic iron oxide: pharmacokinetics and toxicity. Am J Roentgenol 152:167-173.
114. Wu H-Y, Chung M-C, Wang C-C, Huang C-H, Liang H-J, Jan T-R. 2013a. Iron oxide nanoparticles suppress the production of IL-1beta via the secretory lysosomal pathway in murine microglial cells. Part Fibre Toxicol 10:46.
115. Wu H-Y, Chung M-C, Wang C-C, Huang C-H, Liang H-J, Jan T-R. 2013b. Iron oxide nanoparticles suppress the production of IL-1beta via the secretory lysosomal pathway in murine microglial cells. Part Fibre Toxicol 10:46.
116. Wu J, Sun J. 2011. Investigation on mechanism of growth arrest induced by iron oxide nanoparticles in PC12 cells. J Nanosci Nanotechnol 11:11079-11083.
117. Wu J, Ding T, Sun J. 2013c. Neurotoxic potential of iron oxide nanoparticles in the rat brain striatum and hippocampus. Neurotoxicology 34:243-253.
118. 4/DNR magnetic nanoparticles in the treatment of hematologic malignancies. Int J Nanomed 5:1079-1084.
119. Xia T, Kovochich M, Liong M, Meng H, Kabehie S, George S, Zink JI, Nel AE. 2009. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 3:3273-3286.
120. Xiang J-J, Tang J-Q, Zhu S-G, Nie X-M, Lu H-B, Shen S-R, Li X-L, Tang K, Zhou M, Li G-Y. 2003. IONP-PLL: a novel non-viral vector for efficient gene delivery. J Gene Med 5:803-817.
121. Xu P, Li J, Chen B, Wang X, Cai X, Jiang H, Wang C, Zhang H. 2012. The real-time neurotoxicity analysis of Fe3O4 nanoparticles combined with daunorubicin for rat brain in vivo. J Biomed Nanotechnol 8:417-423.
122. Yang C-Y, Hsiao J-K, Tai M-F, Chen S-T, Cheng H-Y, Wang J-L, Liu H-M. 2011. Direct labeling of hMSC with SPIO: the long-term influence on toxicity, chondrogenic differentiation capacity, and intracellular distribution. Mol Imaging Biol 13:443-451.
123. Ying E, Hwang H-M. 2010. In vitro evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytes. Sci Total Environ 408:4475-4481.
124. Yu M, Huang S, Yu KJ, Clyne AM. 2012. Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture. Int J Mol Sci 13:5554-5570.
125. Zhang T, Qian L, Tang M, Xue Y, Kong L, Zhang S, Pu Y. 2012. Evaluation on cytotoxicity and genotoxicity of the l-glutamic acid coated iron oxide nanoparticles. J Nanosci Nanotechnol 12:2866-2873.
126. Zhao J, Castranova V. 2011. Toxicology of nanomaterials used in nanomedicine. J Toxicol Environ Health B Crit Rev 14:593-632.
127. Zhu M-T, Wang Y, Feng W-Y, Wang B, Wang M, Ouyang H, Chai Z-F. 2010. Oxidative stress and apoptosis induced by iron oxide nanoparticles in cultured human umbilical endothelial cells. J Nanosci Nanotechnol 10:8584-8590.
128. Zhu M-T, Wang B, Wang Y, Yuan L, Wang H-J, Wang M, Ouyang H, Chai Z-F, Feng W-Y, Zhao Y-L. 2011. Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis. Toxicol Lett 203:162-171.
129. Zhu X, Tian S, Cai Z. 2012a. Toxicity assessment of iron oxide nanoparticles in zebrafish (Danio rerio) early life stages. PLoS One 7: e46286.
130. Zhu X-M, Wang Y-XJ, Leung KC-F, Lee S-F, Zhao F, Wang D-W, Lai JMY, Wan C, Cheng CHK, Ahuja AT. 2012b. Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines. Int J Nanomed 7:953-964.